- Home
- HHS vs NVNO Comparison
HHS vs NVNO Comparison
Compare HHS & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- NVNO
- Stock Information
- Founded
- HHS 1923
- NVNO 1987
- Country
- HHS United States
- NVNO United States
- Employees
- HHS N/A
- NVNO N/A
- Industry
- HHS Advertising
- NVNO Medical/Dental Instruments
- Sector
- HHS Consumer Discretionary
- NVNO Health Care
- Exchange
- HHS Nasdaq
- NVNO Nasdaq
- Market Cap
- HHS 37.0M
- NVNO 41.0M
- IPO Year
- HHS N/A
- NVNO N/A
- Fundamental
- Price
- HHS $4.52
- NVNO $3.65
- Analyst Decision
- HHS
- NVNO
- Analyst Count
- HHS 0
- NVNO 0
- Target Price
- HHS N/A
- NVNO N/A
- AVG Volume (30 Days)
- HHS 20.2K
- NVNO 76.7K
- Earning Date
- HHS 05-16-2025
- NVNO 05-01-2025
- Dividend Yield
- HHS N/A
- NVNO N/A
- EPS Growth
- HHS N/A
- NVNO N/A
- EPS
- HHS N/A
- NVNO N/A
- Revenue
- HHS $185,242,000.00
- NVNO N/A
- Revenue This Year
- HHS $6.54
- NVNO N/A
- Revenue Next Year
- HHS N/A
- NVNO $409.09
- P/E Ratio
- HHS N/A
- NVNO N/A
- Revenue Growth
- HHS N/A
- NVNO N/A
- 52 Week Low
- HHS $4.27
- NVNO $2.03
- 52 Week High
- HHS $8.87
- NVNO $6.48
- Technical
- Relative Strength Index (RSI)
- HHS 45.88
- NVNO 71.64
- Support Level
- HHS $4.77
- NVNO $2.61
- Resistance Level
- HHS $4.81
- NVNO $3.97
- Average True Range (ATR)
- HHS 0.33
- NVNO 0.22
- MACD
- HHS -0.02
- NVNO 0.11
- Stochastic Oscillator
- HHS 23.17
- NVNO 80.00
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.